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Summary  Overall  prevalence  of  hepatitis  B  (HBV)  in  the  UK  is  low.  However,  among
migrants  from  endemic  areas,  prevalence  has  been  shown  to  be  high.  Furthermore,
timely  diagnosis  and/or  referral  are  required  prevent  serious  health  consequences
through  early  institution  of  treatment.
Methods:  We  identiﬁed  locations  that  would  be  familiar  to  Chinese  members  of  the
community  with  the  objective  of  facilitating  testing.  Dried  blood  spot  samples  were
collected  from  229  Chinese  subjects  and  tested  for  HBV  and  also  for  hepatitis  C  virus
(HCV)  infection  —  offering  complete  chronic  viral  hepatitis  screening.
Results:  HBsAg  was  positive  in  20/229  (8.7%)  participants,  (10  F,  10  M).  Five  women
and  one  man  were  aware  of  their  condition,  but  only  one  man  and  none  of  the
women  were  under  specialist  care.  The  average  length  of  residence  in  the  UK  for
positive  patients  was  15  years  (range  2—40).
Evidence  of  HBV  past  infection,  HBcAb(+)/HBsAg(−), was  seen  in  28/229  partici-
pants  (12.2%).  HCV  antibody  testing  produced  negative  results  in  all  participants.
The  methodology  of  testing  was  well  accepted,  139/144  (95%)  responded  to  a
feedback  questionnaire  declaring  no  discomfort  and  100%  ﬁnding  the  information
session  useful.
Conclusion:  This  model  of  outreach  testing  is  helpful  for  addressing  health  inequal-
ities  afﬂicting  the  UK’s  Chinese  community.
©  2013  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.
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round  two  billion  people  worldwide  are  estimated
o have  evidence  of  current  or  past  infection  with
epatitis  B virus  (HBV).  While  chronic  infection
ffects 350—400  million  people  globally,  around  two
n three  are  estimated  to  remain  undiagnosed,  and
 signiﬁcant  proportion  are  only  diagnosed  at  a time
hen late  complications,  such  as  decompensated
iver cirrhosis  and  hepatocellular  carcinoma,  have
ecome established.  Modes  of  transmission  are
arenteral  contact  with  infected  blood  or  tissue,
erinatal spread,  and  sexual  intercourse.  There
s accordingly  potential  for  this  situation  to  be
mproved  through  earlier  diagnosis,  management
nd treatment,  and  the  institution  of  preventative
nitiatives through  the  use  of  immunization  and  the
ncouragement  of  behavioural  modiﬁcation.
In  December  2012,  the  National  Institute  of
linical Excellence  for  England  and  Wales  issued
n expert-led  guideline  recommending  active
creening in  high-risk  groups,  including  ethnic
roups with  known  high  prevalence  of  HBV  and  hep-
titis  C virus  (HCV)  infections  [1].  This  includes
ndividuals from  China  and  culturally  related
ountries, where  studies  of  migrant  populations
ave revealed  prevalence  of  chronic  HBV  infection
n excess  of  8%  [2],  and  the  major  mode  of  transmis-
ion is  perinatal,  mainly  from  mother  to  child  [3].
n addition,  HCV  is  present  in  China,  with  an  overall
stimated  prevalence  of  3.2%  [4], and  a  high  risk  of
ransmission  has  been  demonstrated  following  use
f unsafe  commercial  blood  products  during  1980s
nd 1990s  [5].
Studies  in  the  UK  and  internationally  have
evealed that  resident  Diaspora  Chinese  popu-
ations manifest  reduced  access  to  health  care
ervices  [6,7].  Reasons  advanced  to  explain  this
ave included  barriers  related  to  cultural  beliefs
r language,  working  patterns,  differential  needs
gainst  the  background  population  and  poorly  tar-
eted healthcare  provision.
In Shefﬁeld,  increasing  immigration  from  Main-
and China  over  the  last  6  years  has  prompted  an
ncrease  in  referrals  to  the  local  HBV  clinic.  How-
ver there  have  been  signiﬁcantly  fewer  referrals
han would  have  been  anticipated  given  the  esti-
ated  chronic  HBV  prevalence  of  greater  than  8%
n this  group.
Dried  blood  spot  (DBS)  sampling  has  advantages
ver traditional  blood  sampling  in  outreach  sett-
ngs: samples  are  easy  to  obtain  with  only  minimal
raining; there  is  a  reduced  risk  of  needle-stick
njury; samples  are  safer  and  easier  to  transport
for example  they  cannot  leak  or  be  broken,  and
o not  require  a  cold  chain);  and  samples  have
d
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he  potential  for  straightforward  storage  at  room
emperature  prior  to  testing  [8].  These  advantages
ave led  to  an  expansion  in  the  use  of  DBS,  includ-
ng screening  for  blood  borne  viruses  such  as  HIV,
epatitis  B  and  C  [9].
A pilot  project  was  established  to  evaluate  a
odel of  testing  for  HBV  utilizing  DBS  sampling  in
utreach  settings,  with  the  aim  of  increasing  HBV
wareness  and  diagnosis,  determining  the  extent  of
he local  gap  in  diagnosis  and  access  to  healthcare
mongst this  group,  and  providing  an  opportunity
or the  collection  of  minimal  epidemiological  data.
aterials and methods
ims
.  To  facilitate  HBV  testing  using  straightforward
methods  in culturally  appropriate  settings  and
to assess  acceptance  of  this  testing  method  by
Chinese  residents.
. To  estimate  the  local  rate  of  undiagnosed  infec-
tion and  to  provide  access  to  expert  healthcare
for those  affected.
etting, dissemination and sampling
he  Kinhon  Chinese  Centre  in  Shefﬁeld  is  a local
uthority-funded  center;  it has  one  full  time  health
romotion  coordinator  and  two  health  promotion
fﬁcers (all  of  them  Chinese  born:  Mandarin  and/or
antonese  speakers)  and  is  actively  involved  in  pro-
iding support  on  social  and  healthcare  matters  to
he Chinese  community.  The  individuals  assisting
his work  therefore  had  both  language  skills  as  well
s appropriate  cultural  and  health  education  knowl-
dge.
The center’s  workers  facilitated  the  organization
f sessions,  including  the  allocation  of  appoint-
ents, ensuring  private  rooms  were  available  to
reserve conﬁdentiality,  and  ensuring  sessions  were
imed to  coincide  with  other  health  promotion
ctivities. Sessions  took  place  in  a room  separated
rom the  main  hall.  Further  sessions  took  place  in
 Chinese  Church,  a  Saturday  Chinese  School  and  a
hinese Wholesalers.
Testing events  were  advertised  in  local  Chinese
anguage newspapers  and  local  bulletins,  posters
isplayed  in  a range  of  community  locations,  and
nformation  given  personally  or  by  phone  to  atten-
ees at  the  centre.
General  Practitioners  were  also  notiﬁed  of  the
creening  pilot  through  notices  posted  in  a local
onthly  GP  bulletin.  In  addition,  from  February
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2012  onwards,  the  times  of  sessions  were  posted
on a  multilingual  website,  speciﬁcally  created  to
provide information  about  the  project  [10].
The sample  was  a  self-selected  sample,  as  it  was
composed  entirely  of  people  requesting  or  volun-
teering for  testing  following  prior  or  on  the  spot
advertisement.
Educational materials
A  leaﬂet  was  devised  to  provide  attendees  with
essential  information  regarding  HBV  transmission,
prevention, treatment  and  alcohol  advice.  This  was
translated  into  Simpliﬁed  Chinese.  The  procedures
for ﬁnger  blood  sampling,  the  timescale  for  pro-
viding  results  and  the  requirements  for  any  further
testing  in  case  of  reactivity  were  also  detailed.
Health promotion  workers  were  trained  in  the
basic information  given  in  the  leaﬂets  and  they  in
turn communicated  this  information  to  the  person
requiring  testing.
Viral hepatitis testing
Hepatitis  B surface  antigen  (HBsAg)  and  total  core
antibody  (HBcAb)  plus  hepatitis  C  antibody  (HCVAb)
testing  was  performed  using  DBS  samples  collected
from the  individuals  in  the  community.  The  DBS
samples  were  collected  on  Whatman  903  grade  ﬁl-
ter paper  and  transported  to  the  Virology  laboratory
at Shefﬁeld  Teaching  Hospitals  NHS  Trust.  In  the  lab-
oratory the  samples  were  eluted  and  tested  using
the ROCHE  COBAS  601  automated  analyzer.  The
assay  had  been  validated  previously  with  a  sensitiv-
ity of  100%  for  HBsAg,  99%  for  HBcAb  as  compared
to serum  result,  and  100%  for  HCVAb  (unpublished
results).
d
w
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Table  1  A  summary  of  demographic  data  and  HBV  test  res
June  2012  (M,  male;  F,  female;  IQR,  interquartile  range).  Ag
Number  (%  of  total)  Media
All  229  (100)  47  
M  102  (42.5)  46  
F  127  (57.5)  48  
Number  (%  of  total)  P
HBsAg  (+) M 10  (9.8) 8
F  10  (7.8)  
HBsAg  (−)  HBcAb
(+)
M 13  (12.7) 1
F  15  (11.8)  
HBsAg  (−)  HBcAb
(−)
M 79  
F  102  A.B.  Vedio  et  al.
If  a positive  result  was  obtained  for  either
BsAg or  HBcAb,  the  patient  was  asked  to  attend
he hospital,  where  a serum  (blood)  sample  was
rawn  and  tested  to  conﬁrm  the  DBS  result  and
he hepatitis  B  status.  Repeat  HBsAg  and  HBcAb
esting  was  performed  on  this  conﬁrmatory  sam-
le, and  further  markers  relevant  to  hepatitis  B
ere tested  as  required  to  clarify  hepatitis  B
tatus. All  results  obtained  by  DBS  were  com-
unicated by  letter  to  the  individual’s  General
ractitioner (GP),  if  a  patient  was  conﬁrmed  to
ave HBsAg  (+)  the  GP  was  asked  to  undertake
esting and  vaccination  of close  contacts  and
amily.
articipant demographics, epidemiology and
eedback
egistration  forms  were  used  to  collect  partic-
pants’ demographics,  name  and  address  of  GP,
lace of  birth  and  number  of  years’  residence
n the  UK,  self-reported  knowledge  of  previous
BV status  and  immunization  status,  and  family
istory  of  hepatitis  and  liver  cancer.  In  addi-
ion, following  the  testing  procedure,  participants
ere asked  to  complete  a short  feedback  ques-
ionnaire, incorporating  both  closed  and  open
uestions.
nalysis
urrent  HBV  infection  was  deﬁned  as  reactivity  for
BsAg in  the  DBS  sample.  Past  HBV  infection  was
eﬁned  as  reactivity  for  HBcAb  in  the  DBS  sample,
ith no  HBsAg  reactivity.
Demographic,  epidemiological  data  and  partici-
ant  feedback  were  collated.
ults  for  participants  recruited  from  September  2009  to
e  is  expressed  in  years.
n  age  IQR  Age  range
33—55  15—86
32—56  15—81
35—55  16—86
revalence  Median  age  IQR  Age  range
.7% 31 29—43  20—73
46  39—53  31—75
2.2% 47 34—56  17—62
47  31—51  26—67
47  33—66  15—81
49  38—57  16—86
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rom  September  2009  to  June  2012,  15  sessions
ere carried  out  at  which  229  people  were  offered
esting. The  demographic  data  and  DBS  results  for
BV are  summarized  in  Table  1.
In  total  10  men  and  10  women  were  diagnosed
ith HBsAg  (+),  giving  an  overall  prevalence  of
.7%. In  addition,  13  men  and  15  women  results
how HBsAg  (−)/HBcAb  (+)  giving  a  prevalence  of
ast infection  of  12.2%.
Five  of  the  participants  (four  females  and  one
ale, age  range  23—43  years)  were  of  Chinese  ori-
in but  were  born  in  the  UK.  Results  were  negative
or all  HBV  markers  in  these  ﬁve  participants.
Results  of  conﬁrmatory  serum  testing  replicated
hose obtained  from  DBS  samples,  except  in  one
ase where  there  was  a  false  positive  HBcAb  DBS
esult.  If  HBsAg  was  detected  in  the  conﬁrmatory
erum sample,  HBV  DNA  testing  was  also  performed
n this  sample.  Two  patients  identiﬁed  as  having
ositive  HBsAg  did  not  attend  for  conﬁrmation,  in
pite of  multiple  attempts  to  contact  them  (they
ere short-term  students  and  it  was  thought  likely
hat they  had  moved  away).  All  surface  antigen
ositive patients  that  attended  for  a  conﬁrmatory
est were  referred  to  a  specialist  clinic.  Individual
pidemiological  data  and  follow-up  results  for  par-
icipants with  current  infection  are  listed  in  Table  2.
HBV-infected  patients  were  comprehensively
linically  assessed,  with  a  full  clinical  history  (they
ere universally  asymptomatic),  physical  examina-
ion, ultrasound  scan  of  the  abdomen,  serum  tests
ncluding  e-markers,  AFP  and  serial  measurements
f liver  function  including  ALT.  Those  fulﬁlling  the
riteria for  active  hepatitis  underwent  liver  biopsy
rior to  commencement  of  treatment.  Details  of
hese elements  are  beyond  the  scope  of  this  paper.
Self reported  diagnosis  showed  that  women  had
he highest  rate  of  having  had  a  previous  diagnosis
f HBV  infection  compared  to  men  (5:1);  none  of
hese  women  were,  however,  under  specialist  care.
n some  cases,  their  HBV  diagnosis  had  been  made
efore the  early  1990s  when  treatment  for  HBV  was
ot available  and  follow-up  not  always  routine.
The average  duration  of  residence  in  the  UK
as 15  years  (17.7  years  for  women  and  13.1
ears for  men,  range  2—40  years)  suggesting  that
ndiagnosed/untreated  chronic  hepatitis  B  can  be
resent in  both  long  term  residents  and  more  recent
rrivals.  Individuals  were  not  asked  speciﬁcally
bout any  subsequent  trips  back  to  China  during  this
eriod.
For 28  individuals  with  past  infection,  average
uration of  residence  in  the  UK  was  11.9  years  (10
or women  and  13  for  men)  and  for  181  attendants
p
t
i
Chinese  residents  451
ith  negative  results  was  17.5  years  (17.4  for
omen  and  17.7  for  men,  data  not  shown).
We requested  feedback  from  the  ﬁrst  155
atients, of  which  144  answered  all  questions  (86%)
11 participants  were  not  able  to  stay  long  enough
o complete  all  questions).  The  feedback  question-
aire results  are  summarized  in  Table  3.
In addition,  38  participants  offered  free  text
omments. All  expressed  a  positive  opinion,  with
xamples  including:
‘Good’’,  ‘‘Very  good  service,  good  information’’,
‘More of  this  screening  please’’,  ‘‘Useful  for  peo-
le to  know  their  state  of  health’’,  ‘‘No  pain  for
eedle  pricking’’,  ‘‘Very  pleased  with  the  test’’,
‘It helps  me  to  look  after  my  health’’.
iscussion
hina  is  one  of  the  countries  with  the  highest  preva-
ence of  HBV  in  the  world,  reported  to  be  9.75%  in
 1996  nationwide  cross-sectional  study  [4]; this  is
 prevalence  level  conﬁrmed  repeatedly  in  further
eports  with  some  regional  variations.  The  main
orm of  transmission  in  China  is  vertical.  Vertical
ransmission perpetuates  itself  due  to  the  resul-
ant tolerant  phase,  which  could  be  decades  long,
ith consequent  high  transmission  rates  to  future
enerations  [3].
Migrant  Chinese  have  been  found  to  have  a  sim-
lar high  rate  of  HBV  infection.  The  prevalence  of
epatitis  B  found  in  this  report  —  8.7%  for  chronic
epatitis B infection  —  is  comparable  with  results
rom studies  in  the  UK  and  USA.  For  example,  in
 cross  sectional  study  where  3163  Asian  Amer-
can citizens  from  California  were  screened  and
urveyed  between  2001  and  2006,  the  prevalence
f infection  was  found  to  be  8.9%;  the  study  also
stablished  that  in  those  individuals  who  were  not
nfected 44.8%  lacked  protective  antibodies  [11].
n our  pilot,  we  were  unable  to  perform  hepatitis
 surface  antibody  testing,  since  this  had  not  been
alidated  locally  with  DBS  samples.  In  the  Califor-
ian study  there  was  an  almost  20-fold  increased
isk of  infection  for  those  born  in  East  Asia  com-
ared to  those  of  East  Asian  origin  but  born  in  the
SA [11]. Unfortunately,  we  were  unable  to  assess
his particular  risk  in  our  cohort,  since  only  5  indi-
iduals had  been  born  in  the  UK.
A 2002  UK  study  of  attendees  at  sexual  health
linics in  London  demonstrated  a higher  prevalence
f hepatitis  B  infection  in  117  ethnic  Chinese  com-
ared with  234  non-Chinese  attendees  [12], with
he prevalence  of  HBsAg  and/or  HBcAb  being  35.5%
n Chinese  and  5.5%  in  non-Chinese.  Non-UK  born
hinese had  a signiﬁcantly  higher  combined  HBV
452  A.B.  Vedio  et  al.
Table  2  Individual  epidemiological  data  for  participants  with  HBsAg  reactivity  on  DBS  sampling  (M,  male;  F,  female;
Y,  yes;  N,  no;  nk,  not  known;  lfu,  lost  to  follow-up).
Gender  Age  (years)  Years  of
UK  resi-
dence
Previous
HBV
diagnosis?*
If yes:
Under
specialist
care?*
Previous
HBV  vac-
cination?
Relatives
with  HBV
infection?
HBV  DNA
(log  IU/ml)
HBV
treatment
required?
F  31  2  N  —  N  N  lfu  lfu
F  34  7  Y  N  N  N  0  N
F  39  2  Y  N  N  Y  2.40  N
F  39  30  Y  N  N  Y  4.18  N
F  41  2  N  —  nk  nk  2.40  N
F  48  7  Y  N  N  N  4.63  N
F  52  33  N  —  N  N  4.81  N
F  53  30  N  —  nk  nk  3.54  Y
F  63  30  Y  N  N  N  6.00  Y
F  74  34  N  —  N  N  3.62  N
M  20  3  N  —  nk  nk  3.39  N
M  26  7  N  —  N  N  4.19  N
M  28  10  N  —  Y  N  5.49  Y
M  29  8  N  —  nk  nk  8.44  N
M  30  8  Y  Y  N  N  3.57  N
M  32  12  N  —  Y  N  lfu  lfu
M  39  nk  N  —  nk  nk  8.50  N
M  43  6  N  —  N  N  2.69  N
M  55  24  N  —  N  N  3.64  Y
M  74  40  N  —  N  N  2.70  N
HBV treatment required: reveals outcomes of patients attending specialist clinics that have been fully assessed between 2009 and
2013.
Table  3  Summary  of  feedback  questionnaire  closed  question  responses  from  144  participants.
Feedback  questionnaire  Yes  No
Number  %  Number  %
1  —  Was  this  session  useful? 144  100  0  0
2  —  Were  you  able  to  ask  all  the  questions  you  had? 135  93.7  9  6.3
3  —  Were  the  explanations  clear? 139  96.5  5  3.5
4  —  Did  the  test  cause  any  discomfort?  8  5  136  95
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arkers  rate  than  UK-born  Chinese  (40.1%  com-
ared  to  6.7%).  HBsAg  positivity  was  detected  in
2.8% of  Chinese  attendees  compared  to  0.4%  in
on-Chinese.  In  addition,  a  study  of  community
ased testing  using  DBS  in  Newcastle,  UK,  reported
 HBV  prevalence  of  10%  in  329  Chinese  subjects,
ith 1.3%  having  had  previous  knowledge  of  their
iagnosis  [13].
An  important  ﬁnding  in  the  present  report  was
hat the  female  Chinese  patients  who  were  aware
f a  previous  diagnosis  had  not  been  referred  to
pecialist  services.  This  omission  may  relate  to  a
ap in  the  knowledge  of  primary  care  practition-
rs, an  area  which  as  yet  has  not  been  formally
tudied in  the  UK  —  although  it  is  of  interest  that
n the  Californian  studies  surveys  of  primary  care
ractitioners  did  identify  such  a  knowledge  gap  —
or example,  only  65%  of  Chinese  asymptomatic
atients had  been  screened  for  HBV  by  general
ractitioners,  with  the  likelihood  of  their  being
creened in  primary  care  being  greater  among  mar-
ied patients  and  those  who  had  been  registered
ith the  practice  for  longer.  In  addition,  it  was
oted that  GPs  of  Asian  origin  are  more  likely  to
creen for  HBV  [14].  A  paucity  of  UK  speciﬁc  studies
xploring  the  reasons  for  a  shortfall  in  HBV  test-
ng and  specialist  referral  by  general  practitioners
ighlights a  need  for  further  research  in  this  area.
f relevance,  aiming  to  address  this  issue,  a  USA
edical  school  have  focused  on  raising  awareness
mong student  doctors  through  modiﬁcation  of  the
ndergraduate  curriculum  and  the  setting  up  of
tudent-led  community  clinics  [15]. In  the  UK  young
emale patients  that  have  not  been  previously  diag-
osed and  may  become  pregnant  will  be  routinely
creened as  part  of  the  Antenatal  Infections  Dis-
ase Screening  Programme  that  has  been  running
ince 1998  and  that  includes  referral  to  specialist
ervices after  diagnosis.  In this  pilot,  of  ﬁve  women
ware  of  previous  diagnosis  that  had  not  been
eferred to  specialist  care,  three  may  have  partici-
ated  on  the  programme  due  to  their  younger  age.
stablishing  barriers  to  referral  affecting  profes-
ionals interacting  with  this  group  deserves  further
tudy.
We recognize  that  there  are  limitations  to  our
ilot. While  we  are  reporting  results  from  a small
ection  of  a  wider  population,  every  effort  was
ade to  ensure  this  was  as  representative  a sam-
le as  possible  by  offering  testing  in  diverse  areas
f gathering.  Also,  it  would  be  desirable  to  test  for
BsAb to  establish  whether  or  not  those  reporting
accination had  developed  a  protective  response
as ordinarily  5—15%  of  healthy  young  adults  and
p to  50%  of  adults  over  60  years  of  age  fail  to
espond adequately  to  the  standard  hepatitis  B
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accines  [18,19]).  However,  despite  its  limitations,
e believe  this  model  is  of  value;  it  could  be  repro-
uced easily  with  only  minimal  modiﬁcations,  and
ight be  applicable  in  other  contexts,  such  as  other
ulturally  diverse  groups.
In addition,  there  are  other  questions  which  need
o be  considered  in  order  to  obtain  a  fuller  picture,
uch as  the  participants’  personal  travel  history,  full
accination history,  any  evidence  of  previous  prob-
ems relevant  to  a possible  past  history  of  personal
BV  infection,  any  evidence  of  screening  during
regnancy,  and  testing  for  HBsAb  titers  to  assess  the
dequacy  of  response  to  any  reported  prior  vacci-
ation  and  for  other  markers  to  HBV  which  might
ndicate  the  presence  of  active  infection  prior  to
heir having  received  any  vaccines,  Further  work  is
ustiﬁed.
Although HCV  is  prevalent  in  certain  areas  of
hina, in  our  experience  only  a  few  migrant  Chi-
ese have  been  referred  to  our  service,  and  the
ilot found  no  positive  results  for  HCV  in  the  groups
creened.  This  may  reﬂect  the  social  circumstances
f those  that  chose  to  migrate  but  we  are  not  able
o draw  conclusions  from  our  results.
ost implications
n  evaluation  of  cost-effectiveness  of  HBV
creening and  treatment  undertaken  in  Canada
emonstrated moderate  cost-effectiveness  [16],
hile a USA  study  estimated  that  a  screening
rogramme  would  be  cost-effective  in  populations
ith an  HBV  prevalence  above  0.3%,  and  empha-
ized that  it  is  the  implementation  of  screening  and
rovision of  treatment  that  will  help  to  decrease
hronic HBV  prevalence,  transmission,  compli-
ations and  mortality  [17]. There  are,  however,
ealth gains  following  screening  and  education  that
annot be  measured  using  only  economic  param-
ters,  such  as  the  wider  beneﬁts  of  engaging  in
ealth promotion  by  families  and  communities  and
ncreased incentivization  to  access  clinical  health
are services.  For  example,  in  our  pilot  a number
f participants  invited  family  members  and  friends
o attend  sessions.  Regular  health  sessions  will
lso have  an  impact  on  other  areas  of  physical  and
ental health,  especially  in  isolated  communities.
olicy and practice implications
he  advantages  and  beneﬁts  of  a patient-centered
creening model  of  the  type  presented  here  can  be
ummarized  as  follows: Its  location  in  a user-friendly  setting  is of  value
to help  reach  persons  that  otherwise  may  never
be tested.
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• Acknowledgement  of  relevant  cultural  and  social
barriers  that  might  prevent  or  reduce  access  to
healthcare  is  of  value.
• The  process  has  the  potential  to  educate  both
patients and  healthcare  and  community  work-
ers, and  encourage  dissemination  of  information
among relatives,  friends  and  other  members  of
the community,  and  the  professional  work  force.
• DBS  testing  is  a  valuable  tool  in  outreach  settings,
as it  represents  an  effective,  safe,  straightfor-
ward, and  well-tolerated  method  of  obtaining
blood.
• Should  it  be  necessary,  DBS  samples  are  easily
and safely  stored  for  prolonged  periods  of  time
at room  temperature  prior  to  their  being  trans-
ported onwards  to  a  central  testing  laboratory.
• The  correlation  between  results  arising  out  of
testing  of  both  DBS  and  conﬁrmatory  venous
blood samples  in  this  study  should  increase  con-
ﬁdence  in  the  methodology.
Issues to be aware of when planning
outreach testing include
• Maintaining  conﬁdentiality:  a  dedicated  private
room  is  ideal  for  the  completion  of  participant
details and  for  testing,  although  on  occa-
sions groups  chose  to  ‘talk  and  test’  together.
Sometimes the  physical  space  available  was
not conducive  to  private  testing,  although  this
problem  could  be  circumvented  with  advanced
planning, with  the  option  of  privacy  being  offered
whenever  possible.
•  Difﬁculties  with  translation:  to  minimize  the
potential  for  misunderstandings,  any  written
material translated  from  English  should  always
be reverse-translated  into  English.  Reverse  trans-
lation  helps  to  identify  erroneous  concepts  and
also proves  useful  in  improving  verbal  com-
munication. Good  supervision  of  interpreters  is
also important.  However,  in  spite  of  reverse-
translation and  the  supervision  of  interpreters,
minor levels  of  misunderstanding  may  still  occur.
• Contact  tracing:  dealing  with  the  unknown  status
of household  contacts  in  UK  residents  originating
from high  endemicity  countries  remains  an  unre-
solved  issue.  In  the  case  of  multiple  household
contacts, this  generates  additional  workload  for
primary health  professionals  and  raises  questions
around the  funding  of  vaccination.Conclusion
This  report  shows  that  in  Shefﬁeld  (UK)  a signiﬁ-
cant number  of  long  term  ethnic  Chinese  residentsA.B.  Vedio  et  al.
nd  more  recently  arrived  individuals  remain  undi-
gnosed  and  untreated  for  hepatitis  B.  Outreach
esting using  DBS  was  well  received  and  may  prove
seful  in  communities  with  recognized  inequalities
n healthcare  access.  This  type  of  model  could  be
lso utilized,  for  example,  to  explore  and  promote
ther areas  of  healthcare  such  as  cardiovascular
isease or  diabetes  mellitus.
The  results  obtained  by  the  DBS  testing  and
alidation process  demonstrate  that  this  is  a safe
nd reliable  method  to  provide  viral  hepatitis
creening, and  it  is  easy  to  use  in  non-healthcare
ettings.
The extension  of  this  type  of  model  to  other
ommunities  such  as  Somali,  Pakistani,  Bangladeshi
nd Eastern  European  communities  among  others
hould be  explored  so  as  to  assess  its  suitability  in
ther ethnic  groups.
Development  of  formal  written  or  electronic
ools for  the  improved  training  and  evaluation  of
ealthcare  and  community  workers  might  be  con-
idered to  work  towards  better  long-term  health
romotion  and  sustainability.
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